---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-053238"
form_type: "8-K"
ticker: "ACET"
cik: "0001720580"
company_name: "Adicet Bio, Inc."
filed_at: "2025-04-11T23:59:59+00:00"
generated_at: "2026-05-23T16:14:14.905989+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Adicet Bio receives Nasdaq delisting notice for bid price below $1; cure period to Oct 6, 2025

## Summary
- Received Nasdaq notice on April 7, 2025 for non-compliance with minimum bid price rule (closing bid <$1 for 30 consecutive days).
- Initial compliance period ends October 6, 2025; must close at or above $1 for at least 10 consecutive days to regain compliance.
- If not cured, may seek additional 180-day period by transferring to Nasdaq Capital Market and meeting other listing standards.
- Company considering reverse stock split as a potential cure; no assurance of regaining compliance or maintaining listing.

## SEC filing metadata
- accession: 0000950170-25-053238
- form_type: 8-K
- ticker: ACET
- cik: 0001720580
- company_name: Adicet Bio, Inc.
- filed_at: 2025-04-11T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1720580/000095017025053238/0000950170-25-053238-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1720580/000095017025053238/acet-20250407.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-053238
- JSON: https://secwatch.observer/filing/0000950170-25-053238.json
- Plain text: https://secwatch.observer/filing/0000950170-25-053238.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.